Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Subsea 7 S.A. Notification of major holding
-
Latham Shares 2023 Environmental, Social And Governance Report
-
LambdaTest Partners with Autify to Enhance No-Code Mobile App Testing with Real Device Support
-
SRS Real Estate Partners Expands Retail Advisory in Washington, D.C. with Veteran Team
-
L.B. Foster Company to Present at Singular Research’s Best of the Uncovereds Conference on December 12, 2024
-
Transaction in Own Shares
-
Crypto’s Fastest-Growing Wallet, Phantom, Integrates Transak
-
Media Advisory: Annual Project Red Ribbon Launch and Tree Lighting Ceremony
-
Tomarket Hits 50M Users, Launches 30% Pre-listing Airdrop
-
NVIDIA to Open Vietnam R&D Center to Bolster AI Development
-
Daniel H. Schulman elected as Verizon lead director
-
AS Eesti Gaas, a subsidiary of Aktsiaselts Infortar, is changing its business name
-
EducationDynamics and DegreeSight Release Report on Reengaging the Some College, No Credential Student Population
-
Milton Hydro Enhances Fleet Efficiency with Innovative Bucket Truck Retrofit
-
Montreal Sales Explode in November
-
Australian Oilseeds Announces Fiscal 2024 Financial Results
-
Farm Fun Continues: Homestead Heritage Holiday Market Brings Fun, Food, and Gift Shopping for Two Additional Saturdays
-
Tonner Drones Secures EUR 900.000 In Non-Dilutive Financing
-
Grady’s Garden® Pasta Sauces Now Available at Jewel-Osco®
-
Canto Launches Canto PIM, Unifying Digital Asset Management and Product Information Management for the Modern Content Lifecycle
-
FirstService Declares Quarterly Cash Dividend on Common Shares
-
Resource Works Welcomes Two New Board Members: Susan Downie-Gagnon and Malcolm Macpherson
-
Mortgage Rates Continue to Decrease
-
Rimidi Completes SOC2 Audit, Reinforcing Commitment to Healthcare Data Security
-
Asimily Successfully Protects Operational Technology in NREL CECA Testing
-
IHA Recognizes California Provider Organizations for Healthcare Performance
-
PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024
-
ORAPI : Droits de vote au 30.11.2024
-
Acentra Health’s Independent Medical Review Division Earns Accreditation from Leading Care Quality and Safety Organization
-
Western Investment Company Announces Closing of Rights Offering
-
Verizon declares quarterly dividend on December 5
-
BIC: Disclosure of total number of voting rights and number of shares forming the capital as of November 30, 2024
-
New generation steps up to continue IBA’s entrepreneurial ownership
-
BIC: Disclosure Of Trading In Own Shares For November 2024
-
Quadient SA - Monthly information on number of shares and voting rights
-
KLÉPIERRE: INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF NOVEMBER 30, 2024
-
Disclosure of the Number of Shares Forming the Capital and of the Total Number of Voting Rights as of 30 November 2024
-
Information Relating to the Total Number of Voting Rights and Shares Forming the Share Capital
-
Konica Minolta Renews IMSA Partnership
-
Good News you Auto-know!
-
Investigating the Genetic and Biological Mechanisms That Predispose to Early-Onset Psychotic Illnesses - A Free Webinar from the Brain & Behavior Research Foundation
-
Investigating the Genetic and Biological Mechanisms That Predispose to Early-Onset Psychotic Illnesses - A Free Webinar from the Brain & Behavior Research Foundation
-
U.S. Army Bronze Medal Available December 5
-
DC Wallet Powered by Radix Announces Partnership with Indian Government Company AFC for CBDC Adoption in India
-
Ahold Delhaize USA Announces Retirement of Food Lion President Meg Ham After Distinguished Career
-
Kalmar Corporation: Share Repurchase 5.12.2024
-
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 5 December 2024
-
FORVIA: Total number of voting rights and shares forming the share capital
-
Qualifacts and Catholic Charities Boston Family Counseling and Guidance Center Partner to Modernize the Center’s Clinical and Billing Processes
-
Wugen to Present Clinical Data at the 2024 ASH Annual Meeting Ahead of Pivotal Trial Launch of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
